NCT07031349 MARPE-Associated Changes in Sleep and Airway
| NCT ID | NCT07031349 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Konya Necmettin Erbakan Üniversitesi |
| Condition | Rapid Maxillary Expansion |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-05-30 |
| Primary Completion | 2025-08-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-05-30 with a primary completion date of 2025-08-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
At the beginning of MARPE treatment (T1) and at the end of the 3-month consolidation phase (T2), patients will complete the teen-STOP-BANG questionnaire and the Pittsburgh Sleep Quality Index (PSQI) to assess the potential benefit of MARPE in reducing the risk of obstructive sleep apnea syndrome (OSAS). Additionally, changes in the upper airway will be evaluated using CBCT images obtained at T1 and T2.
Eligibility Criteria
Inclusion Criteria: Class I malocclusion Maxillary transverse deficiency Age between 15 and 18 years No systemic disease, cleft lip and palate, or speech disorders No history of prior orthodontic treatment Voluntary agreement to participate in the study Good oral hygiene ANB angle between 2° and 5° Exclusion Criteria: Presence of systemic diseases Smoking Poor oral hygiene Lack of cooperation Mental retardation Obesity or nutritional disorders Macroglossia or mandibular retrognathia
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07031349 clinical trial?
This trial is open to participants of all sexes, aged 15 Years or older, up to 18 Years, studying Rapid Maxillary Expansion. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07031349 currently recruiting?
Yes, NCT07031349 is actively recruiting participants. Contact the research team at ssagoglu@gmail.com for enrollment information.
Where is the NCT07031349 trial being conducted?
This trial is being conducted at Konya, Turkey (Türkiye).
Who is sponsoring the NCT07031349 clinical trial?
NCT07031349 is sponsored by Konya Necmettin Erbakan Üniversitesi. The trial plans to enroll 40 participants.